Seul Ki Meang

Title: Inventor Spotlight: Seul Ki Meang from Seoul, KR

Introduction: Seul Ki Meang is an innovative inventor based in Seoul, South Korea. With significant contributions to the field of pharmaceuticals, Meang has developed a formulation that addresses critical challenges in medication administration. His work exemplifies the intersection of creativity and practicality in the realm of healthcare.

Latest Patents: Seul Ki Meang holds one patent titled "Preparation, comprising inclusion complex of varenicline or pharmaceutically acceptable salt thereof, for oral administration." This patent outlines an orally administered pharmaceutical formulation that incorporates an inclusion complex formed with varenicline or its pharmaceutically acceptable salts in cyclodextrin. The invention aims to enhance the experience of medication by effectively masking the bitter taste and reducing irritation during swallowing. Furthermore, it provides oxidation stability for varenicline and improves the drug's solubility.

Career Highlights: Meang is currently employed at CTC Bio, Inc., a company recognized for its advancements in biopharmaceuticals. His role has allowed him to concentrate on innovative solutions that can transform the way pharmaceuticals are delivered and improve patient adherence to medication regimens.

Collaborations: Throughout his career, Seul Ki Meang has collaborated with talented individuals including Hong Ryeol Jeon and Do-Woo Kwon. These partnerships exemplify the importance of teamwork in the innovation process, allowing for diverse perspectives that elevate the quality of their projects.

Conclusion: Seul Ki Meang's contributions to the pharmaceutical field with his innovative patent demonstrate a promising approach to improving drug delivery systems. His work at CTC Bio, Inc. showcases his commitment to enhancing patient care through effective medication solutions. As new challenges arise, inventors like Meang will play a crucial role in driving the future of healthcare innovation.